Nasdaq Clsn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, announces that Dr....

Michael H. Tardugno appointed Executive Chairman of the Board LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:...

Celsion Co. (NASDAQ:CLSN – Get Rating) was the recipient of a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 137,400 shares, a decline of 22.8% from the April 30th total of 177,900 shares. Based on an average daily volume of 319,600 shares, the days-to-cover […]

StockNews.com began coverage on shares of Celsion (NASDAQ:CLSN – Get Rating) in a research report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright assumed coverage on shares of Celsion in a research note on Tuesday. They set a “buy” rating and a $16.00 target price on […]

Wall Street analysts predict that Celsion Co. (NASDAQ:CLSN – Get Rating) will report earnings of ($0.94) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Celsion’s earnings, with the lowest EPS estimate coming in at ($1.08) and the highest estimate coming in at ($0.77). Celsion posted earnings per […]